[250 Pages Report] The virology market is projected to register a CAGR of 5% during the forecast period, up from US$ 2.07 Billion in 2021, to reach a valuation of US$ 3.53 Billion by 2032.
The virology market is anticipated to rise significantly due to public awareness campaigns on the Flu, Zika virus, STDs, AIDS, and Ebola virus, during the forecast period (2022 to 2032).
| Attributes | Details |
|---|---|
| Virology Market Value (2021) | US$ 2.07 Billion |
| Virology Market Value (2032) | US$ 3.53 Billion |
| CAGR (2022 to 2032) | 5% |
The virology market is continually catering to the healthcare sector's preventive and cure demands; yet, some illnesses continue to need R&D of fresh applications, fueling the virology market growth. Virology applications are also used in various therapies and diagnostic processes, fueling virology market expansion.
Another factor driving the growth of the virology market and the demand for the virology process is the expanding applications of virology research in gene therapy, phage treatment, vaccine formulation, and synthetic biology.
Furthermore, the virology market is expanding in numerous forms, such as molecular virology, pediatric virology, computational virology, and many others, resulting in increased research discoveries during the projected period. The possibilities for research are promising, and it is predicted that continued demand for virology process and competent virologists in the foreseeable future.
Some of the vital virology market trends include antiviral therapy advancements in detection techniques, drugs, and vaccines are likely to boost the growth of the virology market. Global efforts are being made to develop innovative vaccines to propel the demand for virology processes and medications to treat virally resistant illnesses, thus promoting virology market growth.
In Phase II studies, for example, Pritelivir, an experimental medicine for herpes simplex virus (HSV) by AiCuris, has proved to be particularly efficient compared to the current conventional antiviral therapies for genital herpes. Extensive research has been undertaken worldwide to treat high-epidemic viral diseases such as Ebola, Dengue, and Malaria.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Modern technologies for identifying and treating viral illness are anticipated to aid global virology market growth.
The virology market continually responds to the healthcare sector's preventative and curative demands.
However, various ailments necessitate R&D for innovative applications, propelling the virology market forward. Furthermore, public awareness campaigns on the Flu, Zika virus, STDs, AIDS, and Ebola virus are also significant factors responsible for increased demand of virology process and virology market growth.
Virology applications are also used in various therapies and diagnostic processes, supporting virology market expansion.
According to the World Health Organization (WHO), all kinds of influenza together create yearly epidemics of 3 to 5 million patients with a severe stage of disease, resulting in 290 000 to 650 000 fatalities globally each year. Although fast diagnostic tests in the virology process are the most often utilized, PCR-based approaches are employed to detect influenza.
Due to technological advancements such as rapid, portable diagnostics, North America is the largest virology market, led by the United States. North America is likely to maintain its virology market leadership during the projection period (2022-2032), owing to a rapid rise in demand for the virology process.
Europe is expected to continue its position as the world's second-largest virology market. Europe is expected to have the greatest CAGR throughout the projected period, owing to improved healthcare infrastructure, easier access to diagnostics, increasing demand for virology process and rising affordability of diagnostic testing for viral infections.
Japan currently has a thriving virology market that is expected to expand at a phenomenal CAGR through 2032. During the projected period, APEJ and Africa are likely to have the most promising virology market growth potential. While China would be the main APEJ market, India will contribute significantly to the APEJ virology industry.
Principal Consultant
GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche are among the key competitors in the global virology market.
The report consists of key players contributing to the virology Market share. This exclusive report analyzes the competitive landscape and virology Market share acquired by key players to strengthen their virology market position.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Report Attribute | Details |
|---|---|
| Growth rate | CAGR of 5% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2015 to 2020 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in USD million, and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis |
| Segments covered | Product, application, end user, region |
| Regional scope | North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia |
| Country scope | USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
| Key companies profiled | GlaxoSmithKline plc; Abbott Laboratories; Boehringer Ingelheim Corporation; Merck and Co. Inc.; Novartis International AG; Siemens; Johnson & Johnson; AstraZeneca AB; and Roche |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
The virology market is likely anticipated to register a CAGR of 5% during the forecast period.
Key players holding substantial virology market share include GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche.
As per the analysis, the virology market share is likely to be US$ 3.53Bn by 2032.
Demand for virology process is anticipated to rise due to public awareness campaigns on diseases and modern technologies for identifying and treating viral illnesses.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Virology Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032 5.3.1. Instruments 5.3.2. Assay Kits 5.3.3. Consumables & Accessories 5.3.4. Software & Data Management 5.3.5. Others 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032 Deep-dive segmentation will be available in the sample on request 6. Global Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032 6.3.1. Disease Diagnosis 6.3.2. Pharmaceuticals 6.3.3. Virology Research 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021 6.5. Absolute $ Opportunity Analysis By Application, 2022-2032 Deep-dive segmentation will be available in the sample on request 7. Global Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Indication 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032 7.3.1. Skin and Soft Tissue Infections 7.3.2. Respiratory Tract Infections 7.3.3. GI Tract Infections 7.3.4. Urinary Tract Infections 7.3.5. Eye Infections 7.3.6. CNS Infections 7.3.7. Sexually Transmitted Diseases 7.3.8. Perinatal Infections 7.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021 7.5. Absolute $ Opportunity Analysis By Indication, 2022-2032 Deep-dive segmentation will be available in the sample on request 8. Global Virology Market Analysis 2017-2021 and Forecast 2022-2032, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032 8.3.1. Hospitals 8.3.2. Clinics 8.3.3. Laboratories 8.3.4. Diagnostic Centers 8.3.5. Blood Banks 8.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021 8.5. Absolute $ Opportunity Analysis By End User, 2022-2032 Deep-dive segmentation will be available in the sample on request 9. Global Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Pacific 9.3.6. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. U.S. 10.2.1.2. Canada 10.2.2. By Product Type 10.2.3. By Application 10.2.4. By Indication 10.2.5. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Application 10.3.4. By Indication 10.3.5. By End User 10.4. Key Takeaways 11. Latin America Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Product Type 11.2.3. By Application 11.2.4. By Indication 11.2.5. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Application 11.3.4. By Indication 11.3.5. By End User 11.4. Key Takeaways 12. Europe Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. U.K. 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Product Type 12.2.3. By Application 12.2.4. By Indication 12.2.5. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Application 12.3.4. By Indication 12.3.5. By End User 12.4. Key Takeaways 13. East Asia Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Product Type 13.2.3. By Application 13.2.4. By Indication 13.2.5. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Application 13.3.4. By Indication 13.3.5. By End User 13.4. Key Takeaways 14. South Asia & Pacific Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Thailand 14.2.1.3. Indonesia 14.2.1.4. Malaysia 14.2.1.5. Singapore 14.2.1.6. Australia 14.2.1.7. New Zealand 14.2.1.8. Rest of South Asia & Pacific 14.2.2. By Product Type 14.2.3. By Application 14.2.4. By Indication 14.2.5. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Application 14.3.4. By Indication 14.3.5. By End User 14.4. Key Takeaways 15. MEA Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Country 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product Type 15.2.3. By Application 15.2.4. By Indication 15.2.5. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Application 15.3.4. By Indication 15.3.5. By End User 15.4. Key Takeaways 16. Key Countries Virology Market Analysis 16.1. U.S. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2021 16.1.2.1. By Product Type 16.1.2.2. By Application 16.1.2.3. By Indication 16.1.2.4. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2021 16.2.2.1. By Product Type 16.2.2.2. By Application 16.2.2.3. By Indication 16.2.2.4. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2021 16.3.2.1. By Product Type 16.3.2.2. By Application 16.3.2.3. By Indication 16.3.2.4. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2021 16.4.2.1. By Product Type 16.4.2.2. By Application 16.4.2.3. By Indication 16.4.2.4. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2021 16.5.2.1. By Product Type 16.5.2.2. By Application 16.5.2.3. By Indication 16.5.2.4. By End User 16.6. U.K. 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2021 16.6.2.1. By Product Type 16.6.2.2. By Application 16.6.2.3. By Indication 16.6.2.4. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2021 16.7.2.1. By Product Type 16.7.2.2. By Application 16.7.2.3. By Indication 16.7.2.4. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2021 16.8.2.1. By Product Type 16.8.2.2. By Application 16.8.2.3. By Indication 16.8.2.4. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2021 16.9.2.1. By Product Type 16.9.2.2. By Application 16.9.2.3. By Indication 16.9.2.4. By End User 16.10. China 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2021 16.10.2.1. By Product Type 16.10.2.2. By Application 16.10.2.3. By Indication 16.10.2.4. By End User 16.11. Japan 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2021 16.11.2.1. By Product Type 16.11.2.2. By Application 16.11.2.3. By Indication 16.11.2.4. By End User 16.12. South Korea 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2021 16.12.2.1. By Product Type 16.12.2.2. By Application 16.12.2.3. By Indication 16.12.2.4. By End User 16.13. India 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2021 16.13.2.1. By Product Type 16.13.2.2. By Application 16.13.2.3. By Indication 16.13.2.4. By End User 16.14. Thailand 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2021 16.14.2.1. By Product Type 16.14.2.2. By Application 16.14.2.3. By Indication 16.14.2.4. By End User 16.15. Indonesia 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2021 16.15.2.1. By Product Type 16.15.2.2. By Application 16.15.2.3. By Indication 16.15.2.4. By End User 16.16. Malaysia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2021 16.16.2.1. By Product Type 16.16.2.2. By Application 16.16.2.3. By Indication 16.16.2.4. By End User 16.17. Singapore 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2021 16.17.2.1. By Product Type 16.17.2.2. By Application 16.17.2.3. By Indication 16.17.2.4. By End User 16.18. Australia 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2021 16.18.2.1. By Product Type 16.18.2.2. By Application 16.18.2.3. By Indication 16.18.2.4. By End User 16.19. New Zealand 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2021 16.19.2.1. By Product Type 16.19.2.2. By Application 16.19.2.3. By Indication 16.19.2.4. By End User 16.20. GCC Countries 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2021 16.20.2.1. By Product Type 16.20.2.2. By Application 16.20.2.3. By Indication 16.20.2.4. By End User 16.21. South Africa 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2021 16.21.2.1. By Product Type 16.21.2.2. By Application 16.21.2.3. By Indication 16.21.2.4. By End User 16.22. Israel 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2021 16.22.2.1. By Product Type 16.22.2.2. By Application 16.22.2.3. By Indication 16.22.2.4. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Application 17.3.4. By Indication 17.3.5. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Thermo Fisher Scientific, Inc. 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Merck KGaA 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Eurofins Scientific S.E. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. QIAGEN N.V. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Becton, Dickinson and Company 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Danaher Corporation 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. NeoGenomics, Inc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Biolog, Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. IEH Laboratories & Consulting Group 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. VWR Corporation 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 18.1.11. Altogen Labs 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.11.5.2. Product Strategy 18.1.11.5.3. Channel Strategy 18.1.12. STERIS Plc. 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.12.5.2. Product Strategy 18.1.12.5.3. Channel Strategy 18.1.13. Dynatec Labs 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.13.5.2. Product Strategy 18.1.13.5.3. Channel Strategy 18.1.14. Wickham Laboratories Ltd. 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 18.1.14.5.2. Product Strategy 18.1.14.5.3. Channel Strategy 18.1.15. Charles River Laboratories Inc. 18.1.15.1. Overview 18.1.15.2. Product Portfolio 18.1.15.3. Profitability by Market Segments 18.1.15.4. Sales Footprint 18.1.15.5. Strategy Overview 18.1.15.5.1. Marketing Strategy 18.1.15.5.2. Product Strategy 18.1.15.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Virology Market
